Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TMED7-TICAM2 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
mRNA | TSPAN6 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | TTC27 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
mRNA | BLK | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
mRNA | EEPD1 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
mRNA | GPR55 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
mRNA | MAGEA9 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
mRNA | CALML4 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
mRNA | MPST | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
mRNA | CA13 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |